NCT00106834View on ClinicalTrials.gov

A Study of the Safety and Efficacy of Infliximab in Patients With Psoriasis

PHASE3CompletedINTERVENTIONAL
Enrollment

378

Participants

Timeline

Start Date

Not specified

Study Completion Date

October 31, 2004

Conditions
Psoriasis
Interventions
DRUG

Infliximab

Sponsors

Lead Sponsor

Centocor, Inc.
All Listed Sponsors
lead

Centocor, Inc.

INDUSTRY

NCT00106834 - A Study of the Safety and Efficacy of Infliximab in Patients With Psoriasis | Biotech Hunter | Biotech Hunter